References
- Bhattamisra SK, Khanna VK, Aggarwal AK, Singh PN, Singh SK (2008): Antidepressant activity of standardized extract of Marsilea minuta Linn. J Ethnopharmacol. 117: 51–57.
- Calarasu C (1989): Pharmaceutical containing diphenhydramine and Echinaceae and Eupatorium and Gelsemium and Lachesris for the treatment of psoriasis and neurodermititis. German Patent No. 3641220, 4, 1988. Chem Abstr. 110: 141559.
- Dhawan K, Kumar S, Sharma A (2001): Antianxiety studies on extract of Passiflora incarnata Linneaus. J Ethnopharmacol. 78: 165–170.
- Dunham MW, Miya TS (1957): A note on a simple apparatus for detecting neurological deficits in rats and mice. J Am Pharm Assoc Sci. 46: 208–209.
- Emamghoreishi M, Khasaki M, Aazam MF (2005): Coriandrum sativum: Evaluation of its anxiolytic effect in the elevated plus-maze. J Ethnopharmacol. 96: 365–370.
- Farnsworth NR (1966): Biological and phytochemical screening of plants. J Pharm Sci. 55: 225–286.
- Felter HW, Lloyd JU (1983): Gelsemium (U.S.P.) – Gelsemium. In: King’s American Dispensatory [online]. Avaliable at: http://www.ibilio.org/herbmed/kings/gelsemium.htm. Accessed 23 August 2006.
- Hoggs S (1996): A review of the validity and variability of the elevated plus maze as an animal model of anxiety. Pharmacol Biochem Behav. 54: 21–30.
- Jensen SR, Kirk O, Nielsen BJ, Norrestam R (1987): 9-Hydroxy substituted iridiods from Gelsemium sempervirens. Phytochemistry. 26: 1725–1731.
- Kogure N, Nishiya C, Kitajima M, Takayama H (2005): Six new indole alkaloids from G. sempervirens Ait. Tetrahedron Lett. 46: 5857–5861.
- Kulkarni SK, Reddy DS (1996): Animal behavioural models for testing antianxiety agents. Method Findings Exp Clin Pharmacol. 18: 219–230.
- Kumar S, Sharma A (2006): Apigenin – the anxiolytic constituent of Turnera aphrodisiaca Ward. Pharm Biol. 44: 84–90.
- Lister RG (1987): The use of a plus maze to measure anxiety in the mouse. Psychopharmacology. 92: 180–185.
- Mitte K, Noack P, Steil R, Hautzinger M (2005): A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder. J Clin Psychopharmacol. 25: 141–150.
- Nebera SA, Nebera OA, Pakhomova NN (2003): Homoeopathic preparation for treating myopia. RU Patent No. 2203674. Chem Abst. 139: 219298.
- OECD (1996). Test No. 423: Acute oral toxicity – acute toxic class method. In: OECD Guidelines for the Testing of Chemicals. Paris, OECD.
- Pellow S, Chopin P, File SE, Briley M (1985): Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 14: 149–176.
- Peng W, Hsieh M, Lee Y, Lin Y, Liao J (2000): Anxiolytic effect of seed of Ziziphus jujube in mouse models of anxiety. J Ethnopharmacol. 72: 435–441.
- Rabbani M, Sajjadi SE, Jafarian A, Vaseghi G (2005): Anxiolytic effect of Salvia reuterana Bioss on the elevated plus maze model of anxiety in mice. J Ethnopharmacol. 101: 100–103.
- Raupp IM, Sereniki A, Virtuoso S, Ghislandi C, Cavalcanti e Silva EL, Trebien HA, Miguel OG, Andreatini R (2008): Anxiolytic-like effects of chronic treatments with Erythrina velutina extract in the elevated plus-maze test. J Ethnopharmacol. 118: 295–299.
- Reynolds EH (2003): Brain and mind: A challenge for WHO. Lancet. 361: 1924–1925.
- Rodgers RJ (1997): Animal model of anxiety: Where next? Behav Pharmacol 8: 477–496.
- Voorhees J, Nachman L (2002): Herbal composition for treating symptoms of influenza. United States Patent No. 64550703. Chem Abstr. 137: 159364.
- Wenkert E, Chang CJ, Corchan DW, Polliccari R (1972): 13C nuclear magnetic resonance spectroscopy of naturally occurring substances, VIII. Structure of gelsevirine. Experientia. 28: 377–379.
- WHO (2001): The world health report 2001 – Mental health: New understanding, new hope. Geneva, WHO.